Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
Sep 29, 2025 • 3min
September 2025 Capitol Hill Report: BrainPAC Update
In this episode, Dr. Andy Southerland discusses the Capitol Hill Report from September 8, providing important updates around BrainPAC. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Sep 26, 2025 • 3min
Overcoming Colonialism in Pathogen Genomics
Dr. Deanna Saylor and Dr. Senjuti Saha discuss colonialism in global health and the importance of pathogen genomics. Show reference: https://www.thelancet.com/journals/landig/article/PIIS2589-7500(24)00091-8/fulltext
Sep 25, 2025 • 3min
Exploring Treatment Approaches in Pediatric MOG Antibody–Associated Disease A Survey of Neurologists - Pat 2
In the final episode of this two-part series, Dr. Justin Abbatemarco discusses long-term maintenance therapy options. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200504
Sep 24, 2025 • 4min
Exploring Treatment Approaches in Pediatric MOG Antibody–Associated Disease A Survey of Neurologists - Pat 1
In part one of this two-part series, Dr. Justin Abbatemarco discusses what we know and don't know surrounding MOG antibody–associated diseases (MOGADs). Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200504
Sep 23, 2025 • 3min
Outcomes Following Acute Plasma Exchange for MOGAD - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss how to approach discontinuation of immunotherapy in clinical practice. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
Sep 22, 2025 • 2min
Outcomes Following Acute Plasma Exchange for MOGAD - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss a long-term maintenance approach for MOGAD. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
Sep 19, 2025 • 3min
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 2
In part two of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the future of addressing intolerable suffering in practice and explore the opportunities for MAID. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
Sep 18, 2025 • 2min
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 1
In part one of this two-part series, Dr. Robert Holloway and Dr. Carolyn Rennels discuss the main takeaway points from the paper. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200478
Sep 17, 2025 • 3min
Outcomes Following Acute Plasma Exchange for MOGAD - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213903
Sep 16, 2025 • 4min
Safety and Efficacy of Satralizumab in Patients with Generalized MG
Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00514-3/fulltext
